Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 6/13/2025Abbisko Therapeutics' Pimicotinib Earns NMPA Nod for TGCT NDA Review
  • 6/13/2025AB‑RayBio Secures Multi‑Million CNY Angel Investment
  • 6/13/2025AstraZeneca Enters Strategic Deal with CSPC Pharma Focused on AI-enabl...
  • 6/13/2025Nona and Visterra Partner to Advance Next-Gen Biotherapeutics for Immu...
  • 6/12/2025Hengrui Advances DLL3‑Targeting ADC SHR‑4849 with Phase II China Tri...
  • 6/12/2025CF PharmaTech Files for Hong Kong IPO
  • 6/12/2025Cloudbreak Advances Ophthalmic Pipeline, Pursues Hong Kong IPO
  • 6/12/2025InnoVec Raises Tens of Millions in Series A+ to Accelerate Gene Therap...
  • 6/11/2025MediLink Therapeutics Lines Up Major Banks for Hong Kong IPO Push
  • 6/11/2025Ligachem Inks Dual ADC Licensing Deals with CSPC Subsidiary Novarock
  • 6/10/2025BIOSeedin 2025 Showcases China's Rise as Global Biotech Innovator
  • 6/10/2025Pfizer CEO Highlights Chinese Data Due Diligence to Support $6B Bispec...
  • 6/10/2025Transpire Enters License Deal with Intragrand Pharma for Investigation...
  • 6/10/2025Green Valley Halts Sales of Alzheimer's Drug GV-971 Amid Regulatory Un...
  • 6/10/2025Innogen Pharma Files for Hong Kong Listing, Accelerates Pipeline Devel...
  • 6/9/2025Kelun-Biotech Secures US$250M in Upsized HK Share Placement
  • 6/9/2025Everest Presents Positive Results from Phase 1b/2a Trial of EVER001 fo...
  • 6/9/2025China Exempts U.S. Drugs & Medical Supplies from Retaliatory Tariffs
  • 6/9/2025YolTech's YOLT‑101 Wins FDA IND Clearance as China Licensee Salubris ...
  • 6/7/2025QureBio Secures ~CNY 100M in Series C1 Financing to Advance BsAb Thera...
  • 6/6/2025Zelgen and Merck Partner to Launch China's First rhTSH Therapy for Pos...
  • 6/5/2025Cullinan Secures Global Rights to Genrix's Velinotamig
  • 6/3/2025BioAge Partners with JiKang Thera for APJ Agonist After Obesity Drug S...
  • 6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval
  • 6/3/2025LongBio Secures Over CNY 200M in Series C Financing
  • 6/3/2025Neowise Licenses TCR Candidate to BeiGene for Off-the-Shelf Cell Thera...
  • 6/3/2025Hanx Biopharma Files for Hong Kong IPO to Advance Innovative Cancer Th...
  • 6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...
  • 6/2/2025Regeneron Licenses Hansoh's Dual GLP-1/GIP Receptor Agonist to Bolster...
  • 6/2/2025VelaVigo Expands Global Footprint with Strategic U.S. Biotech Collabor...
  • Page:1/23 Total number of articles:667: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group